Recursion Pharmaceuticals, Inc.

Ownership Transactions Reported by 22 Insiders

Symbol
RXRX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
41 S Rio Grande Street, Salt Lake City, UT

Insiders trading volume in the past year

Recursion Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Lux Ventures IV, L.P. Former 10% Owner $138M Dec 7, 2021
Mubadala Investment Co PJSC 10%+ Owner $137M Mar 2, 2023
Blake Borgeson Director $49.1M -$1.41M -2.78% Jan 2, 2025
Zachary Bogue Director, 10%+ Owner $39.5M Jul 3, 2023
Dean Y. Li Director $19.3M Apr 1, 2025
MIC Capital Partners (Public) Parallel Cayman, LP 10%+ Owner $14.7M Nov 1, 2021
Michael Secora Chief Financial Officer $9.19M -$1.29M -12.4% Nov 15, 2024
Christopher Gibson Chief Executive Officer, Director $6.75M -$5.55M -45.1% Mar 27, 2025
Najat Khan Chief R&D Commercial Officer, Director $5.16M Feb 3, 2025
Ben R. Taylor Chief Financial Officer $4.29M Apr 1, 2025
Tina Marriott President and COO $3.13M -$267K -7.85% Nov 15, 2024
Shafique Virani Chief Business Officer $1.45M Jan 16, 2024
David J. Mauro Chief Medical Officer $1.39M Nov 15, 2024
Ramona Doyle Chief Medical Officer $1.28M May 16, 2022
Zavain Dar Director $670K Apr 1, 2025
Franziska Michor Director $649K Nov 20, 2024
Chavez R. Martin Director $530K Apr 1, 2024
Terry-Ann Burrell Director $514K Jul 1, 2024
Robert Hershberg Director $454K Jun 3, 2024
Elaine D. Sun Director $233K Mar 17, 2025
Namandje Bumpus Director $233K Mar 17, 2025
Mic Capital Partners (Public) (Us) Im, Llc Other* Nov 1, 2021

Recent Insider Transactions by Companies or Individuals for Recursion Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.